Why are TFFP's administrative costs declining?

The administrative costs of TFF Pharmaceuticals (TFFP) have shown a decreasing trend over the past months, with the latest reported figure being $2.08 million for the period ending Q3 2024. This decline can be attributed to several factors:

1. **Wind-down of Operations**: TFFP has been winding down its operations, which likely led to a reduction in administrative expenses as the company has been focusing on dissolving rather than expanding its business.
2. **Strategic Prioritization**: The company has prioritized the clinical development of TFF TAC, potentially reallocating resources from other areas, including administration, to focus on this key program.

In summary, the decline in administrative costs for TFFP can be attributed to a combination of winding down operations and strategic prioritization of clinical development.